Related Experiment Video
Updated: Jun 12, 2026
04:41
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Fukinolic acid facilitates toxic amyloid-β oligomerization and exacerbates synaptic dysfunction
Hye Ji Chae1, Huiyoung Kwon2, So-Ri Son3
1Department of Pharmacology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.
Summary
Fukinolic acid (FA) surprisingly accelerates amyloid-β (Aβ) aggregation and worsens neurotoxicity in Alzheimer's disease models. This compound may exacerbate synaptic dysfunction via NMDA receptor pathways, necessitating caution in its therapeutic evaluation.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Alzheimer's disease (AD) involves amyloid-β (Aβ) aggregate accumulation, leading to synaptic dysfunction and neuronal loss.
- Soluble Aβ oligomers are the most neurotoxic species, driving AD progression.
- Fukinolic acid (FA), a plant-derived polyphenol, has known antioxidant and anti-inflammatory effects but its impact on Aβ is unknown.
Purpose of the Study:
- To investigate the effects of FA on Aβ aggregation and Aβ-induced synaptic dysfunction.
- To explore the underlying mechanisms of FA's action on Aβ pathology.
Main Methods:
- Molecular docking simulations to predict FA-Aβ interactions.
- In vitro assays measuring Aβ aggregation and neuronal cytotoxicity.
- Electrophysiological recordings (long-term potentiation, LTP) in hippocampal slices.
- In vivo studies using 5XFAD transgenic mice.
Main Results:
- Molecular docking predicted FA interaction with Aβ monomers.
- FA promoted toxic Aβ oligomer formation and enhanced Aβ-induced neuronal cytotoxicity.
- FA exacerbated Aβ-induced LTP impairment, dependent on NMDA receptor signaling.
- In 5XFAD mice, FA increased Aβ deposition and reduced neuronal viability.
Conclusions:
- FA promotes the formation of toxic Aβ oligomers.
- FA may worsen Aβ-associated synaptic impairment through NMDA receptor-dependent mechanisms.
- Further research is needed to clarify FA's in vivo effects on synaptic and cognitive function in AD.
Keywords:
Alzheimer’s diseaseAmyloid-β oligomerizationFukinolic acidN-methyl-D-aspartic acid receptorSynaptic dysfunctionMore Related Videos
06:17A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
09:52Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
Published on: December 28, 2017
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...